Vertex VERX 深 滬
等待開盤 12-19 09:30:00 美东时间
20.50
+0.040
+0.20%
華盛通- 最 高20.82
- 今 開20.47
- 成交量 27.16万股
- 最 低 20.45
- 昨 收 20.46
- 總市值 32.80亿
- 52周最高 60.71
- 市盈率 靜 --
- 換手率 0.17%
- 52周最低 18.5428
- 委 比 80.24%
- 總股本 1.60亿
- 歷史最高 60.71
- 量 比 0.45
- 振 幅 1.81%
- 歷史最低 9.44
- 每 手 1
- 風險率 11.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多专利悬崖下，2026 药企并购潮将至
（来源：抗体圈） 专利压力成核心推手 “2026 到 2027 年，我们将迎来一轮大规模并购季。”Coya Therapeutics CEO 阿伦・斯瓦米...
12-17 14:51
Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million
Royalty Pharma has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib for up to $315 million. Both drugs are next-generation tyrosine kinase inhibitors targeting non-small cell lung cancer patients with ALK or ROS1 mutations. Neladalkib has shown positive pivotal results and is in Phase 3 testing, while zidesamtinib is under FDA review with an action date in September 2026. Analysts project $3.5 billion and $1.9 bi...
12-16 12:15
AI Tokens Vs. AI Stocks: Promises Vs. Profits
Artificial intelligence dominates market conversations, spawning two competing investment narratives. One rides on blockchain promises and decentralized computing dreams. The other ships actual chips, generates billions in profit, and pays real dividends. As we head toward 2026, the gap between AI cryptocurrency tokens and traditional AI stocks isn’t just wide.
12-16 00:53
Oracle Database@Google Cloud is Now Available in Canada
Powerful multicloud database service will help customers in Canada improve analytics and AI productivity, address data residency regulations, and accelerate IT modernization Industry-first r...
12-11 22:37
Google Cloud Makes Enterprises AI-Ready With Nutanix NC2
Alphabet Inc.'s Google Cloud and Nutanix, Inc. launch Nutanix Cloud Clusters platform on Google Compute Engine.
12-10 01:25
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Dec. 9, 2025 /PRNewswire/ -- Equity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrou...
12-10 00:57
Monolithic Power, Ascendis Pharma And More: CNBC's 'Final Trades'
Amy Raskin, CIO at Chevy Chase Trust, named Ascendis Pharma (ASND) as her final trade on CNBC's Halftime Report. FDA extended review for TransCon CNP.
12-09 21:16
【海外瞭望】谷歌发布新一代图像生成模型Nano Banana Pro，2030年全球电视和视频市场或将达万亿美元
综合整理|李雪凝 人工智能 谷歌 Veo 3.1 视频生成模型，提供视频编辑功能 近日，谷歌Veo3.1 版本支持在视频中添加对象，并自动将其融入原有...
12-09 11:13
波司登哈尔滨举办极地发布会，极寒系列助力中国南北极考察
“从珠峰之巅到南北两极，人类的极限探索在哪里，波司登科技创新的坐标就定位在哪里。”波司登品牌创始人高德康在哈尔滨太阳岛极地发布会上分享道。
12-08 17:47
Reported Saturday, Vertex Announces Pivotal CASGEVY Studies In Children Ages 5-11 Years Showing Transformative Potential And Consistent Efficacy And Safety Versus Ages 12 Years And Older
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients --
12-08 17:35
